Renin-angiotensin system inhibitors improve the clinical outcomes of COVID-19 patients with hypertension
Emerging Microbes & Infections
J. Meng et al.

Abstract
ABSTRACT
The dysfunction of the renin-angiotensin system (RAS) has been observed in coronavirus infection disease (COVID-19) patients, but whether RAS inhibitors, such as angiotensin-converting enzyme inhibitors (ACEIs) and angiotensin II ty